
– NASDAQ:MEDRX
stock price today
key metrics
Market Cap | 19.35M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freestock price history
stock forecast
financial statements
other data
-
What's the price of stock today?
One share of stock can currently be purchased for approximately $31.22.
-
When is 's next earnings date?
Unfortunately, 's (MEDRX) next earnings date is currently unknown.
-
Does pay dividends?
No, does not pay dividends.
-
How much money does make?
has a market capitalization of 19.35M.
-
What is 's stock symbol?
null is traded on the NASDAQ under the ticker symbol "MEDRX".
-
What is 's primary industry?
Company operates in the Financial Services sector and Asset Management industry.
-
How do i buy shares of ?
Shares of can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When went public?
null is publicly traded company for more then 6 years since IPO on 2 Jan 2019.
-
How can i contact ?
can be reached via phone at +800 9303828.
company profile:
NASDAQ
0
Asset Management
Financial Services
The fund is a non-diversified fund that invests all of its investable assets in the Medical Portfolio, a series of Kinetics Portfolios Trust. The Portfolio invests at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants, and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries, with an emphasis toward companies engaged in cancer research and drug development. It is non-diversified.
,
CIK: 0001083387
:
: